NCT00006043View on ClinicalTrials.gov

Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2000

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Ovarian CancerTesticular Germ Cell Tumor
Interventions
DRUG

temozolomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006043 - Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin | Biotech Hunter | Biotech Hunter